Clinical Trials Logo

Major Depression clinical trials

View clinical trials related to Major Depression.

Filter by:
  • Suspended  
  • Page 1

NCT ID: NCT02890212 Suspended - Major Depression Clinical Trials

Selenium as Augmentation Treatment for Sertraline Resistant Major Depression

Start date: August 2005
Phase: N/A
Study type: Interventional

The main goals of antidepressant treatments are to achieve remission of depressive episodes and prevent recurrences. However, clinical trials designed to approve antidepressants targets a response rate of at least 50%, which is considered partially effective. Therefore, there is a need for new treatment strategies, including augmentation with other substances such as lithium. This research aims to verify through a pilot study, the effect of selenium as an augmentation treatment for sertraline-resistant major depression. This clinical trial was designed to be a randomized, placebo-controlled, double-blind trial evaluating the effect of selenium or placebo in subjects diagnosed with major depression who have not responded to treatment with sertraline